Pharma & biotech

Pfizer upgrades guidance for sales of covid-19 vaccine

The US pharmaceutical company Pfizer now predicts sales of its coronavirus vaccines will total USD 33.5bn this year. The previous estimate was UDS 26bn. Meanwhile, the company has revealed the guidance for its annual revenue.

FDA gives Saniona candidate priority status

The US FDA has given biotech firm Saniona's drug candidate Tesomet priority status as an orphan drug for treating hypothalamic obesity. Earlier this year, Tesomet received the same priority status as a treatment for Prader-Willi syndrome.

Sweden phases out AstraZeneca's covid-19 vaccine

89 percent of the Swedish population above the age of 65 are fully vaccinated, meaning authorities in Sweden are phasing out the use of the AstraZeneca vaccine. In Stockholm, residents now have a choice of vaccines.

Trial banner

Latest news

See all jobs